Skip to main content

Table 2 Studies of maternal prenatal urinary phthalate metabolites and fetal growth outcomes measured in utero

From: Fetal growth in environmental epidemiology: mechanisms, limitations, and a review of associations with biomarkers of non-persistent chemical exposures during pregnancy

Reference

Country, years

N

Urinary phthalate metabolites

Timing of urine collection

in utero outcome(s)

Timing of outcome assessment

Notes1

All2

Girls2

Boys2

Zhao et al. 2014 [97]

China

2012-2013

126

MBP, MMP

∑DEHP: MEHP, MEHHP, MEOHP

3rd trimester

IUGR

3rd trimester

 

+ IUGR (MEHHP)

  

Zhao et al. 2015 [126]

China

2011-2013

119

MBP, MMP

∑DEHP: MEHP, MEHHP, MEOHP

3rd trimester

Growth restricted (IUGR or low birth weight)

not specified

 

+ Growth restricted (MEHP, MEHHP, MEOHP, ∑DEHP)

  

<37 weeks only

NS

  

≥37 weeks only

+ Growth restricted (MEHHP, MEOHP, ∑DEHP)

  

Botton et al. 2016 [99]

France

2003-2006

520

∑LMW: MEP, MBP, MiBP

∑HMW: MBzP, MCOP, MCPP, MCNP, MECPP, MEHHP, MEOHP, MEHP

∑DEHP: MECPP, MEHHP, MEOHP, MEHP

26 weeks

EFW

AC

BPD

HC

FL

12 weeks

   

̵ BPD (MBzP, ∑HMW, MECPP, MEHHP, MEOHP, ∑DEHP)

22 weeks

   

- EFW (MBzP, MCNP)

- BPD (MBzP, MCPP, ∑HMW, MECPP, MEHHP, MEOHP, MEHP, ∑DEHP)

+ FL (MCNP)

32 weeks

   

- BPD (MCPP, ∑HMW, MECPP, MEHHP, MEOHP, MEHP, ∑DEHP)

+ FL (MCNP)

overall pregnancy

   

- EFW (∑HMW, MECPP, MEHHP)

- BPD (MBzP, ∑HMW, MECPP, MEOHP, ∑DEHP)

+ FL (MCNP)

Casas et al. 2016 [100]

Spain

2004-2006

390

MBzP

∑LMW: MEP, MiBP, MnBP;

∑DEHP: MEHP, MEHHP, MEOHP, MECPP

12, 32 weeks**

EFW

AC

BPD

HC

FL

12 weeks

not adjusted for GA

NS

NS

NS

20 weeks

- HC (MnBP)

NS

NS

34 weeks

+ FL (MBzP)

+ FL (MBzP)

NS

growth rate 12-20 weeks

- EFW (MnBP)

- HC (MnBP)

- HC (MnBP)

- HC (MnBP)

growth rate 20-34 weeks

+ FL (MBzP)

+ FL (MBzP)

+ EFW (MnBP)

+ AC (MnBP)

Ferguson et al. 2016 [101, 102]

USA

2006-2008

482

MEP, MBP, MiBP, MBzP, MCPP

∑DEHP: MECPP, MEHHP, MEOHP, MEHP

10, 18, 26, 35 weeks**

EFW

AC

HC

FL

26, 35, 38 weeks

 

- EFW (MEOHP, MECPP, ∑DEHP)

- AC (MECPP, ∑DEHP)

- HC (MECPP, MBzP)

- FL (MECPP, ∑DEHP)

- EFW (MECPP, ∑DEHP)

- HC (MEP)

- AC (∑DEHP)

- FL (MEHHP, MEOHP, ∑DEHP)

  1. 1Unless otherwise specified, studies included term, preterm, parous, and nulliparous births, and models of birth outcomes adjusted for or standardized to gestational age.
  2. 2Blank cells indicate associations were not examined; NS indicates that associations within that category were examined but not statistically significant at p<0.05.
  3. *Average of two or more urine samples.
  4. Abbreviations. AC, abdominal circumference; BPD, biparietal diameter; EFW, estimated fetal weight; FL, femur length; GA, gestational age; HC, head circumference; IUGR, intrauterine growth restriction, defined as estimated fetal weight below the 10th centile for gestational age; MBP, monobutyl phthalate; MBzP, monobenzyl phthalate; MCOP, monocarboxy-isooctyl phthalate; MCNP, monocarboxy-isononyl phthalate; MCPP, mono-3-carboxypropyl phthalate; MEP, monoethyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate; MEHP, mono-2-ethylhexyl phthalate; MEOHP, mono-2-ethyl-5-oxohexylphthalate; MiBP, monoisobutyl phthalate; MMP, monomethyl phthalate; MnBP, mono-n-butyl phthalate; ∑DEHP, molar sum of the di-2-ethylhexyl phthalate metabolites that follow; ∑HMW, molar sum of the high molecular weight phthalate metabolites that follow; ∑LMW, molar sum of the low molecular weight phthalate metabolites that follow.